GW Pharma (GWPH) Posts Near-Breakeven Q4 Profit
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Wall St futures muted as oil gains curb risk appetite after S&P record close
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- Reddit to join S&P 500 index on Aug. 18, shares leap
GW Pharma (GWPH) Bullish Stance Reiterated at Piper Jaffray Following Earnings, Conference and Dinner
December 4, 2014 7:14 AM ESTPiper Jaffray analyst Joshua Schimmer reiterated an Overweight rating and $147 price target on GW Pharma (NASDAQ: GWPH) following fireside chat with GWPH management (along with a dinner with management) at the 26th annual Piper Jaffray Healthcare Conference in New York yesterday. GWPH... More
